Saad Sabbagh (@SaadMSabbagh) profile picture

PGY2 IM Resident @CleveClinicFl | Post-doctoral Research Fellow @Cancer_CCFla | MD ‘22 @AUBMC_Official |

Florida, USA
Joined January 2022
Excited to share our latest publication in @JAMANetworkOpen on biomarker testing disparities in metastatic colorectal cancer. Honored to work with the incredible team, mentors, and collaborators at @Cancer_CCFla @CleveClinicFL @drznahleh @ArunNagarajanMD @SWexner
In a national cohort of patients with metastatic colorectal cancer, older age, lower educational level, community-setting treatment, South-Central US divisions, and rural areas of residence were associated with decreased MSI and KRAS testing. ja.ma/4cLWaDu
11
7
2
63
9,714
Grateful to receive the best poster award for our work on factors predictive of lymph node dissection in patients with Upper Tract Urothelial Carcinoma. Huge thanks to @PierettiAlberto @CleveClinicFL for the mentorship and continuous support! #AUA24
9
1
52
4,908
Factors predictive of lymph nodes Dissection performance in UTUC! #AUA2024 @CleClinicUro @CleveClinicFL @Cancer_CCFla @FlaUrological
1
4
23
1,474
Adjuvants vs Neoadjuvant chemotherapy in high-risk UTUC! #AUA2024 @CleClinicUro @CleveClinicFL @FlaUrological
2
14
640
Saad Sabbagh retweeted
A national analysis evaluating the role of lymph node dissection in patients with high-risk upper tract urothelial carcinoma. Presented by @SaadMSabbagh @CleveClinicFL. #SESAUA2024 written coverage by @zklaassen_md @GACancerCenter on UroToday > bit.ly/4antkbu @SES_AUA
1
3
8
1,771
Replying to @SUO_YUO
6
16
1,929
Our paper is out now in @FrontOncology! Are treatment and sequencing options influencing outcomes in patients with HR+ HER2- metastatic breast cancer? @Layalmahmasani @DrHazemAssi
New research: Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancer: Introduction Metastatic breast cancer (MBC) is a diverse disease. Therapeutic options include… frontiersin.org/articles/10.… #oncology
2
12
2,388
The time has come #MedTwitter! I’m an #IMG from @AUBMC_Official and research fellow at @CleveClinicFL Excited to be applying for the #InternalMedicine match! #Match2024 Passionate about clinical research and healthcare equity Wishing everyone the best of luck! #Match2024
30
2
127
10,514
Honored to have had the opportunity to present our work at the annual #AACR 2023 conference. Credits to the mentors @ArunNagarajanMD @HSaterMD @drznahleh and @Cancer_CCFla team who made it possible.
10
50
3,663
Published in Cancers as part of the Special Issue: Treatment Modalities for Non-small Cell Lung Cancer— a Clinical Survey. @SaadMSabbagh @MiraItaniMD @DomingBarbara @DianaSaravia @drznahleh @artetabulos @MDPIOpenAccess #Cancer #oncology #CancerAwareness
1
2
17
1,452
Grateful for the opportunity to have 2 abstracts accepted for poster presentation at @AACR Annual Meeting 2023! Thank you @Cancer_CCFla @drznahleh @ArunNagarajanMD @HSaterMD @DomingBarbara @dr_jabbal #AACR23
4
2
1
46
5,340
This is what it’s all about for me: getting more residents & fellows interested in #lungcancer research. @FLASCO_ORG Early Lung Cancer Summit with research fellows @HemOncWomenDocs @SamuelKareffMD @SylvesterCancer @SaadMSabbagh @CleveClinicFL #lcsm
2
11
71
4,308
Great to see our team Fellows and Faculty presenting innovative research ⁦@FLASCO_ORG⁩ from ⁦@Cancer_CCFla⁩ ⁦@ChaulagainMD⁩ and congratulations ⁦@SaadMSabbagh⁩ and ⁦@ArunNagarajanMD⁩ 👏
3
7
1
31